This study demonstrates for the first time that DKK-1 may be a strong determinant of structural damage at baseline among patients with early RA and may be an independent predictor of slow structural progression defined by increased mSHS >1 within 2 years of follow-up. This evidence concerns the gene DKK1 and rheumatoid arthritis.